EUVIMEDEUVIMED entdecken
Crossref

Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension

Gamze Vuran iD, Murat Muhtar Yılmazer iD, Engin Gerçeker iD, Cüneyt Zihni iD, Timur Meşe iD

Cardiology in the Young · 2024

DOI: 10.1017/s1047951124000362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology in the Young, 2024. Verfasst von Gamze Vuran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, University of Health Sciences, İzmir Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital,…. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Leukotriene B4, Heart Defects, Congenital, Pulmonary Artery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aim of this study is to evaluate the role of leukotriene B4, an inflammatory mediator, in the development of pulmonary hypertension in paediatric patients with CHD with left-right shunt.

Methods

The study included forty patients with CHD with left-right shunts. Based on haemodynamic data obtained from cardiac diagnostic catheterisation, 25 patients who met the criteria for pulmonary arterial hypertension were included in the patient group. The control group comprised 15 patients who did not meet the criteria. The standard cardiac haemodynamic study was conducted. Leukotriene B4 levels were assessed in blood samples taken from both pulmonary arteries and peripheral veins.

Results

The median age of patients with pulmonary arterial hypertension was 10 months (range: 3–168), while the median age of the control group was 50 months (range: 3–194). In the pulmonary hypertension group, the median pulmonary artery systolic/diastolic/mean pressures were 38/18/24 mmHg, compared to 26/10/18 mmHg in the control group. Leukotriene B4 levels in pulmonary artery blood samples were significantly higher in the pulmonary arterial hypertension group compared to the controls (p < 0.05). Peripheral leukotriene B4 levels were also elevated in the pulmonary arterial hypertension group in comparison to the control group, though the difference was not statistically significant.

Conclusion

The discovery of elevated leukotriene B4 levels in pulmonary artery samples from paediatric patients with pulmonary arterial hypertension secondary to CHD with left-to-right shunt suggests that local inflammation may have a pathological role in the development of pulmonary arterial hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryLeukotriene B4Heart Defects, CongenitalPulmonary ArteryHumansFemaleMaleChildChild, PreschoolAdolescentInfantBiomarkersCase-Control StudiesCardiac CatheterizationHemodynamics

Stichwörter der Autor:innen

CHDinflammationleukotriene B4pulmonary arterial hypertension

Substanzen

Leukotriene B4Biomarkers

Autor:innen und Institutionen

  • Department of Pediatric Cardiology, University of Health Sciences, İzmir Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, İzmir, Turkey.

ORCID-Profile: Gamze Vuran, Murat Muhtar Yılmazer, Engin Gerçeker, Cüneyt Zihni, Timur Meşe

Zitieren

APA

Vuran, G., Yılmazer, M. M., Gerçeker, E., Zihni, C., & Meşe, T. (2024). Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension. Cardiology in the Young. https://doi.org/10.1017/s1047951124000362

Vancouver

Vuran G, Yılmazer MM, Gerçeker E, Zihni C, Meşe T. Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension. Cardiology in the Young. 2024. doi:10.1017/s1047951124000362

BibTeX
@article{Vuran2024,
  author = {Vuran, Gamze and Yılmazer, Murat Muhtar and Gerçeker, Engin and Zihni, Cüneyt and Meşe, Timur},
  title = {Leukotriene B4 levels in CHD-associated paediatric pulmonary hypertension},
  journal = {Cardiology in the Young},
  year = {2024},
  doi = {10.1017/s1047951124000362}
}
Kostenlos starten →